Histopathological analysis of the IFN-γ-treated APOL1-transgenic mice revealed that G1/G1 and G2/G2 mice also developed glomerulosclerosis, with characteristics similar to those seen in humans. The gene discussed is APOL1; the disease is glomerulosclerosis.